BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10206650)

  • 1. Band-3 crosslinking-induced targeting of mouse carrier erythrocytes.
    Jordán JA; Alvarez FJ; Tejedor MC; Díez JC
    Biotechnol Appl Biochem; 1999 Feb; 29(1):59-65. PubMed ID: 10206650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo behaviour of rat band 3 cross-linked carrier erythrocytes.
    Jordán JA; Alvarez FJ; Lotero LA; Tejedor MC; Díez JC
    Biochimie; 1998 Apr; 80(4):325-32. PubMed ID: 9672753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking treatment of loaded erythrocytes increases delivery of encapsulated substance to macrophages.
    Alvarez FJ; Jordán JA; Calleja P; Lotero LA; Olmos G; Díez JC; Tejedor MC
    Biotechnol Appl Biochem; 1998 Apr; 27(2):139-43. PubMed ID: 9569609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential induction of macrophage recognition of carrier erythrocytes by treatment with band 3 cross-linkers.
    Jordán JA; Alvarez FJ; Lotero LA; Olmos G; Calleja P; Tejedor MC; Díez JC
    Biotechnol Appl Biochem; 1998 Apr; 27(2):133-7. PubMed ID: 9569608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of mouse erythrocytes by band 3 crosslinkers.
    Jordán JA; DeLoach JR; Luque J; Díez JC
    Biochim Biophys Acta; 1996 Aug; 1291(1):27-34. PubMed ID: 8781521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery to macrophages of interleukin 3 loaded in mouse erythrocytes.
    Olmos G; Lotero LA; Tejedor MC; Diez JC
    Biosci Rep; 2000 Oct; 20(5):399-410. PubMed ID: 11332601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of oxidation and crosslinking on oxygen binding properties of mouse erythrocytes.
    Lotero LA; Jordán JA; López RM; García-Pérez AI; Diez JC
    Cell Biochem Funct; 2001 Jun; 19(2):89-95. PubMed ID: 11335933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro properties and organ uptake of rat band 3 cross-linked erythrocytes.
    Jordán JA; Murciano JC; Lotero A; Herráez A; Díez JC
    Biochimie; 1997; 79(1):53-61. PubMed ID: 9195046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro phagocytosis of carrier mouse red blood cells is increased by Band 3 cross-linking or diamide treatment.
    Jordán JA; Alvarez FJ; Lotero LA; Herráez A; Díez JC; Tejedor MC
    Biotechnol Appl Biochem; 2001 Dec; 34(3):143-9. PubMed ID: 11730481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution of 125I-labelled carbonic anhydrase isozymes I, II and III in the rat.
    Appelgren LE; Odlind B; Wistrand PJ
    Acta Physiol Scand; 1989 Nov; 137(3):449-56. PubMed ID: 2512769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo survival and organ uptake of loaded carrier rat erythrocytes.
    Alvarez FJ; Herráez A; Murciano JC; Jordán JA; Díez JC; Tejedor MC
    J Biochem; 1996 Aug; 120(2):286-91. PubMed ID: 8889812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined effect of IDA and glutaraldehyde on the erythrocyte membrane proteins.
    Marczak A; Walczak M; Jóźwiak Z
    Int J Pharm; 2007 Apr; 335(1-2):154-162. PubMed ID: 17158004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosslinking of membrane proteins during erythrocyte ageing.
    Gaczyńska M; Bartosz G
    Int J Biochem; 1986; 18(4):377-82. PubMed ID: 3709928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct evidence for modulation of porter quaternary structure by transport site ligands.
    Salhany JM; Sloan RL
    Biochem Biophys Res Commun; 1989 Mar; 159(3):1337-44. PubMed ID: 2930564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo liver and lung targeting of adriamycin encapsulated in glutaraldehyde-treated murine erythrocytes.
    Zocchi E; Tonetti M; Polvani C; Guida L; Benatti U; De Flora A
    Biotechnol Appl Biochem; 1988 Dec; 10(6):555-62. PubMed ID: 3148305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocytes as carriers for L-asparaginase. Methodological and mouse in-vivo studies.
    Kravtzoff R; Ropars C; Laguerre M; Muh JP; Chassaigne M
    J Pharm Pharmacol; 1990 Jul; 42(7):473-6. PubMed ID: 1980286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulated red blood cell survival by membrane protein clustering.
    Chiarantini L; Rossi L; Fraternale A; Magnani M
    Mol Cell Biochem; 1995 Mar; 144(1):53-9. PubMed ID: 7791745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fullerenol C₆₀(OH)₃₆ could associate to band 3 protein of human erythrocyte membranes.
    Grebowski J; Krokosz A; Puchala M
    Biochim Biophys Acta; 2013 Sep; 1828(9):2007-14. PubMed ID: 23702461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous administration of carrier erythrocytes: slow release of entrapped agent.
    DeLoach JR; Corrier DE
    Biotechnol Appl Biochem; 1988 Aug; 10(4):359-64. PubMed ID: 3219194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlike its human counterpart, band 3 anion exchange protein from goat erythrocyte membrane shows a lack of reactivity against various -SH oxidants and protease treatments.
    Khan MT; Saleemuddin M
    Comp Biochem Physiol B Biochem Mol Biol; 1995 Feb; 110(2):339-43. PubMed ID: 7719641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.